Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.

Source:http://linkedlifedata.com/resource/pubmed/id/12224817

Download in:

View as

General Info

PMID
12224817